Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
eli lilly
2
×
fda
life sciences
national blog main
national top stories
abbvie
allergan
amgen
avapritinib
biohaven
blueprint medicines
boston
boston blog main
boston top stories
cgpr
cstone pharmaceuticals
deals
europe blog main
european medicines agency
fisogatinib
flatiron health
genentech
hepatocellular carcinoma
investing
jeff albers
medullary thyroid cancer
merck
migraine
national
new york blog main
non-small cell lung cancer
pralsetinib
roche
san francisco blog main
san francisco top stories
selpercatinib
thermo fisher scientific
thyroid cancer
What
fda
2
×
medicines
wins
2
×
adults
allergan
approval
approved
blueprint
cancer
candidate
class
currently
drug
marketing
migraine
monday
muscle
new
nod
pact
pill
regulatory
ret
review
roche
team
treat
treatment
ubrelvy
ubrogepant
Language
unset
Current search:
wins
×
fda
×
" eli lilly "
×
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines